[HTML][HTML] Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA. 2.86, EG. 5.1, and JN. 1
Z Tong, J Tong, W Lei, Y Xie, Y Cui, G Jia, S Li… - Cell Reports, 2024 - cell.com
The game between therapeutic monoclonal antibodies (mAbs) and continuously emerging
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA. 2.86, EG. 5.1, and JN. 1
Z Tong, J Tong, W Lei, Y Xie, Y Cui, G Jia, S Li… - Cell … - pubmed.ncbi.nlm.nih.gov
The game between therapeutic monoclonal antibodies (mAbs) and continuously emerging
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
[PDF][PDF] Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA. 2.86, EG. 5.1, and JN.
Z Tong, J Tong, W Lei, Y Xie, Y Cui, G Jia, S Li… - Cell …, 2024 - researchgate.net
The game between therapeutic monoclonal antibodies (mAbs) and continuously emerging
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA. 2.86, EG. 5.1, and JN. 1.
Z Tong, J Tong, W Lei, Y Xie, Y Cui, G Jia, S Li… - Cell Reports, 2024 - europepmc.org
The game between therapeutic monoclonal antibodies (mAbs) and continuously emerging
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
[HTML][HTML] Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA. 2.86, EG. 5.1, and JN. 1
Z Tong, J Tong, W Lei, Y Xie, Y Cui, G Jia, S Li… - Cell Reports, 2024 - Elsevier
The game between therapeutic monoclonal antibodies (mAbs) and continuously emerging
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has favored the …